期刊文献+

原发性肺NK/T细胞淋巴瘤24例临床分析 被引量:5

Clinical analyses of 24 patients with primary pulmonary NK/T-cell lymphoma
原文传递
导出
摘要 目的探讨原发性肺NK/T细胞淋巴瘤的临床特点、最佳治疗方案及预后因素,以提高对原发性肺NK/T细胞淋巴瘤的认识。方法回顾性分析2011年4月至2019年5月收治的24例明确诊断为原发性肺NK/T细胞淋巴瘤患者的临床资料,并对其临床特征、治疗及预后进行分析。采用Kaplan-Meier进行生存分析,应用Cox比例风险回归模型确定影响总生存(OS)期和疾病无进展生存(PFS)期的预后因素。结果①入组的24例患者中男16例,女8例,中位年龄为49(4~76)岁。②患者初始症状大多为发热(66.7%)、咳嗽、呼吸困难。主要的胸部影像学表现为单侧(45.8%)或双侧(54.2%)肺部浸润、结节或肿块。③24例患者中20例接受放化疗或造血干细胞移植,4例接受姑息治疗。所有患者的中位OS期为9.5(0.1~26.0)个月,1年OS率为45.8%。以门冬酰胺酶为基础化疗方案的总有效率(ORR)为88.2%。④单因素分析显示,年龄≤60岁患者的OS和PFS显著优于年龄>60岁的患者(P值分别为0.002、0.004),美国东部肿瘤协作组体能状态评分(ECOG评分)≤2分患者的OS和PFS显著优于ECOG评分>2分患者(P值分别为0.042、0.004)。多因素分析显示,年龄>60岁和ECOG评分>2分与不良OS和PFS相关(OS:P值分别为0.024、0.024;PFS:P值分别为0.035、0.024)。结论原发性肺NK/T细胞淋巴瘤罕见且预后差,以门冬酰胺酶为基础的化疗方案疗效显著,年龄>60岁和ECOG评分>2分是患者独立的不良预后因素。 Objective To explore the clinical characteristics,the best treatment and prognostic factors of primary pulmonary NK/T-cell lymphoma.Methods A total of 24 cases with primary pulmonary NK/T-cell lymphoma from April 2011 to May 2019 were analyzed retrospectively.Survival analysis was performed using the Kaplan-Meier method and groups were compared using the log-rank test.Multivariate analysis using Cox proportional hazard regression model was conducted to confirm independent prognostic factors for overall survival(OS)and progression-free survival(PFS).Results①The cohort of 24 patients included 16 male and 8 female with a median age of 49 years(range,4-76 years)old.②Most patients initially presented with a fever(66.7%),cough and dyspnea.Chest imaging manifestations were primarily unilateral(45.8%)or bilateral(54.2%)pulmonary consolidation,nodules or mass.③20 patients received chemotherapy,radiotherapy or hematopoietic stem cell transplantation,the rest 4 cases palliative treatment.Median OS was 9.5 months(range,0.1-26.0 months).The estimated 1-year OS rate was 45.8%.Overall response rate of patients treated with asparaginase-based regimen was 88.2%.④In univariate survival analysis,age≤60 was prognostic for longer OS and PFS,compared with age>60(P=0.002 and 0.004,respectively);ECOG≤2 was prognostic for longer OS and PFS,compared with ECOG>2(P=0.042 and 0.004,respectively).In multivariate survival analysis,age>60 and ECOG>2 were significantly correlated with inferior OS and PFS(OS:P=0.024 and 0.024,respectively;PFS:P=0.035 and 0.024,respectively).Conclusions Primary pulmonary NK/T-cell lymphoma was a rare disease with poor prognosis.Asparaginase-based regimens appeared to be effective.Age and ECOG served as independent prognostic factors for primary pulmonary NK/T-cell lymphoma patients.
作者 邱亚娟 张明智 Qiu Yajuan;Zhang Mingzhi(Department of Respiratory,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Department of Oncology,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)
出处 《中华血液学杂志》 CAS CSCD 北大核心 2020年第1期40-46,共7页 Chinese Journal of Hematology
基金 国家自然科学基金(81570203) 河南省卫生科技英才海外研修项目(HWYX2019039)。
关键词 原发性肺淋巴瘤 NK/T细胞淋巴瘤 预后 Primary pulmonary lymphoma NK/T-cell lymphoma Prognosis
  • 相关文献

参考文献1

二级参考文献9

  • 1刘勇,杨海玉,路名芝.鼻型NK/T细胞淋巴瘤研究新进展[J].中华病理学杂志,2005,34(12):809-812. 被引量:6
  • 2上官宗校,周建英.原发性肺恶性淋巴瘤的研究进展[J].国际呼吸杂志,2006,26(2):117-121. 被引量:16
  • 3苏欣,宋勇,施毅,石群立,孟奎,陈自谦,张文东.累及肺脏的NK/T细胞淋巴瘤一例[J].中华结核和呼吸杂志,2006,29(2):140-141. 被引量:1
  • 4Cadranel J, Wishz M, Antoine M. Primary pulmonary lymphoma. Eur Respir J, 2002,20:750-762.
  • 5Kurtin PJ, Myers JL, Adlakha H, et al. Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type. Am J Surg Pathol, 2001,25 : 997- 1008.
  • 6Laohaburanakit P, Hardin KA. NK/T cell lymphoma of the lung: a case report and review of literature. Thorax, 2006, 61: 267- 270.
  • 7Lee BH, Kim SY, Kim MY, et al. CT of nasal-type T/NK cell lymphoma in the lung. J Thorac Imaging, 2006,21:37-39.
  • 8Jaffe ES, Harris NL, Stein H, et aL World Health Organization classification of tumors, pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
  • 9Jaffe ES, Harris NL, Vardiman JW, et al. World Health Organization classificatlon of tumors, pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001,204-207.

共引文献7

同被引文献54

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部